Nabo, Loreno S.

HRN: 27-85-08  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2025
CEFTRIAXONE 1G (VIAL)
09/22/2025
09/29/2025
IV
1535mg
BID
Typhoid Fever, UTI
Remove - Pending Acceptance
09/23/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
09/23/2025
09/30/2025
TOPICAL
1ml
QID
Oral Sores
Remove - Pending Acceptance
09/26/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/26/2025
10/03/2025
IV
250mg
Q6
Sepsis
Waiting Final Action 
09/26/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/26/2025
10/03/2025
IV
250mg
Q6
Sepsis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: